Antioxidant, Burnout, Professional, Psychological Distress
Conditions
Keywords
Pomegranate, Burnout, Psychological Distress, Antioxidant
Brief summary
Medical students and residents have high rates of mental distress and burnout related to the intellectual and time demands of their training. Research shows that physiological stress on the body can be a result of fatigue and high stress work, and is associated with experiences related to mental distress. Pomegranate is a fruit that is known to contain a variety of antioxidant substances that can reduce physiological stress. This study will look at the potential for pomegranate supplementation to reduce physiological stress and improve well-being in medical students and residents.
Detailed description
This is a pilot study to investigate the feasibility of conducting a randomized trial of pomegranate supplementation in medical students and residents, and to see whether there is evidence of an effect on reported emotional and physical well-being. Phase 1 will be a pilot with 10 participants in which all will receive the pomegranate supplement for 28 days. In phase 2, we will randomize 40 participants (1:1) to receive either the pomegranate supplement or a placebo. For both phases, we will measure self reported emotional and physical well-being using several questionnaires, and we will conduct laboratory testing for measures of oxidative stress and inflammatory biomarkers in blood, and for a metabolite of pomegranate in urine.
Interventions
DIETARY_SUPPLEMENTPomella pomegranate extract
Participants will take a 500 mg capsule of pomegranate extract twice daily for 28 days.
OTHERPlacebo
Participants will take a gelatin placebo twice daily for 28 days.
Sponsors
University of Rhode Island
University of Mississippi Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)
Masking description
Phase 1 is not masked, but in phase 2 the participants and investigator will be masked (double blind).
Intervention model description
Phase 1 is a single group feasibility pilot in 10 participants, all of whom will receive the nutritional supplement. Phase 2 is a parallel double blinded trial in 40 participants, half of whom will receive the supplement and half of whom will receive a placebo.
Eligibility
Sex/Gender
ALL
Age
21 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* First or second year medical student or first or second year resident listed at the University of Mississippi Medical Center
Exclusion criteria
* Pregnant or planning to become pregnant during the study period. * Breast feeding. * Unable to speak, understand, and read English. * Taking chronic medications other than contraception * Taking supplements (including over-the-counter multivitamins) * Allergy to pomegranate or gelatin (gel-caps) * Baseline scores on the DASS-21 that indicate a level of depressive or anxiety symptoms that is severe or extremely severe. This would be a depression score greater than 10, or an anxiety score greater than 7.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in Scores on Maslach Burnout Inventory over time | baseline, 4 weeks , 8 weeks | Survey instruments |
| Changes in health as measured by scores on the RAND Short-Form 12 over time | baseline, 4 weeks , 8 weeks | Survey instrument |
| Changes in fatigue as measured by the Iowa Fatigue Scale over time | baseline, 4 weeks , 8 weeks | Survey instrument |
| Changes in mental health symptoms measured by the Depression/Anxiety/Stress Scale (21) over time | baseline, 4 weeks , 8 weeks | Survey instrument |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in serum total oxidative stress over time | baseline, 4 weeks, 8 weeks | Serum laboratory test |
| Change in Th2 cytokine levels from peripheral blood and culture supernatants over time | baseline, 4 weeks, 8 weeks | Immunologic test |
| Change in Serum total antioxidant capacity over time | baseline, 4 weeks, 8 weeks | Serum laboratory test |
| Change in TREG cytokine levels from peripheral blood and culture supernatants over time | baseline, 4 weeks, 8 weeks | Immunologic test |
| Change in Th17 cytokine levels from peripheral blood and culture supernatants over time | baseline, 4 weeks, 8 weeks | Immunologic test |
| Change in Th1 cytokine levels from peripheral blood and culture supernatants over time | baseline, 4 weeks, 8 weeks | Immunologic tests |
| Change in Th1 cytokine levels from peripheral blood and culture supernatants | baseline, 4 weeks, 8 weeks | Immunologic test |
| Change in Urinary Urolithins over time | baseline, 4 weeks, 8 weeks | Urinary metabolite of pomegranate |
Countries
United States
Outcome results
None listed